Nabi Biopharmaceuticals
A company developing preventive measures and treatments for diseases and vaccines addressing nicotine addiction
2
Funding Rounds
$7.8m
Money raised
Funding
Funding series
Funding Series Analysis
The company Nabi Biopharmaceuticals has raised a total of $7.75m in funding over 2 rounds.
Key Insights:
- Nabi Biopharmaceuticals Series B round: $6.25m
- Nabi Biopharmaceuticals Series A round: $1.5m
Nabi Biopharmaceuticals Series B round
$6.25m
Nabi Biopharmaceuticals Series A round
$1.5m
Industries
Nabi Biopharmaceuticals is active in the following industries: